LinksHomepageStock List Search by Ticker News Login |
Merck & Company (NYSE:MRK)
|
|
The following stock analysis is based on 10.7 years of data (i.e. since Jul 23, 2012). All the stock history has been downloaded.
Merck & Company trades on the NYSE exchange in USD dollars.
It is in the healthcare sector.
It is currently trading at $106.39 ($105.92 the previous day).It pays a 2.61% dividend.
The next reporting date is in 26 days (2023 04 27).
CNN estimates profits for the upcoming quarter will be $1.37 per share ($13.8B). The current Canada / US exchange rate is 1.3511.
Over the past 12 months, $0 worth of shares have been purchased and $310255092 worth of shares have been sold by insiders.
The year over year average increase is 13.7% per year assuming steady exponential growth. The actual 5 year average is 10.26. Details on the individual increase in one year intervals is provided below.
| Past Performance | Average Price | Percent Change | |
|---|---|---|---|
| 1 year | 96.110210447761 | 23.9 | + Above Average |
| 2 year | 77.541553246753 | -2.7 | - Below Average |
| 3 year | 79.661856395349 | -4.2 | - Below Average |
| 4 year | 83.130812745098 | 18.8 | + Above Average |
| 5 year | 69.94858778626 | 15.5 | + Above Average |
The worst drop it has had in recent years is -27.5%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.
| DAYS AG0 | PRICE | |
| 10 | 106.97 | DROPPING |
| 30 | 110.59 | DROPPING |
| 60 | 108.59 | RISING |
| 150 | 97.71 | RISING |
| 365 | 79.3 | RISING |
| 800 | 82.34 | DROPPING |
| 1200 | 88.98 | DROPPING |
| 1600 | 75.48 | RISING |
| 2000 | 64.6 | RISING |
Starter Stock Portfolio: 15 Safe Stocks To BuyThu, 30 Mar 2023 15:02:16 In this article, we will take a look at the 15 safe stocks to buy. To see more such companies, go directly to Starter Stock Portfolio: 5 Safe Stocks To Buy. Amid the current market turmoil which seems to have no end ...... Read Full Article |
Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27Thu, 30 Mar 2023 10:45:00 RAHWAY, N.J., March 30, 2023--Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27... Read Full Article |
11 Best Dow Jones Dividend Stocks According to Hedge FundsThu, 30 Mar 2023 10:38:02 In this article, we discuss 11 best Dow Jones dividend stocks according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Dow Jones Dividend Stocks According ...... Read Full Article |
India exempts import tax on pricey rare disease medicinesThu, 30 Mar 2023 09:18:00 The Indian government said on Thursday it was providing a full exemption from basic customs duty for rare disease therapies and Merck and Co Inc's cancer therapy Keytruda when such medicines were imported for personal use. The government said in ...... Read Full Article |
FDA Converts to Full Approval Indication for KEYTRUDA® (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid TumorsWed, 29 Mar 2023 20:15:00 RAHWAY, N.J., March 29, 2023--FDA Converts to Full Approval Indication for KEYTRUDA for Certain Adult and Pediatric Patients With Advanced MSI-H or dMMR Solid Tumors... Read Full Article |
Stocks trade higher at the open, tech sees gainsWed, 29 Mar 2023 13:42:37 Yahoo Finance Live’s Brad Smith breaks down how stocks are trading following the opening bell on Wednesday.... Read Full Article |
Merck (MRK) Dips More Than Broader Markets: What You Should KnowTue, 28 Mar 2023 21:45:09 In the latest trading session, Merck (MRK) closed at $105.53, marking a -1.31% move from the previous day.... Read Full Article |
12 Best Diversified Dividend Stocks to Buy NowTue, 28 Mar 2023 19:10:17 In this article, we discuss 12 diversified dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Diversified Dividend Stocks to Buy Now. Diversified companies ...... Read Full Article |
Merck Releases Keytruda Data In Frontline Endometrial Cancer PatientsTue, 28 Mar 2023 16:50:33 Merck and Co Inc (NYSE: MRK) announced results from the Phase 3 NRG‑GY018 trial of Keytruda (pembrolizumab) combined with standard-of-care chemotherapy (carboplatin and paclitaxel), then continued as a single agent every six weeks for up to 14 cycles for the first-line ...... Read Full Article |
Health Rounds: Waiting to remove lymph nodes may improve cancer immunotherapyTue, 28 Mar 2023 15:55:15 Surgeons often remove cancer patients' lymph nodes to see if the disease has spread beyond the tumor, but modern cancer drugs that boost immune responses might work even better if lymph nodes are left in place, new research shows. The ...... Read Full Article |
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma, Regardless of Mismatch Repair StatusMon, 27 Mar 2023 21:15:00 RAHWAY, N.J., March 27, 2023--KEYTRUDA® Plus Chemotherapy Significantly Improved PFS Compared to Chemo Alone as 1L Therapy for Advanced or Recurrent Endometrial Carcinoma... Read Full Article |
Investors Heavily Search Merck and Co., Inc. (MRK): Here is What You Need to KnowMon, 27 Mar 2023 13:00:01 Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.... Read Full Article |
What Makes Merck and Co. (MRK) A Strong Investment?Mon, 27 Mar 2023 06:31:33 Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund returned 10.57% gross of fees, underperforming the Russell 1000 Value ...... Read Full Article |
Who Are Pfizer's (PFE) Main Competitors?Sat, 25 Mar 2023 17:38:05 Pfizer's biggest competitors in the global pharmaceutical industry are Johnson and Johnson, Roche, Eli Lilly, AbbVie, Novo Nordisk, and Merck.... Read Full Article |
Amplifying the Power of Women in ChemistryWed, 22 Mar 2023 19:45:00 Merck and Co., Inc.... Read Full Article |
The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and HalliburtonWed, 22 Mar 2023 11:21:11 Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton are part of the Zacks top Analyst Blog.... Read Full Article |
Merck (MRK) Stock Sinks As Market Gains: What You Should KnowTue, 21 Mar 2023 21:45:09 In the latest trading session, Merck (MRK) closed at $105.54, marking a -0.29% move from the previous day.... Read Full Article |
Top Research Reports for Merck, Intel and MercadoLibreTue, 21 Mar 2023 14:52:02 Today's Research Daily features new research reports on 16 major stocks, including Merck and Co., Inc. (MRK), Intel Corporation (INTC) and MercadoLibre, Inc. (MELI).... Read Full Article |
7 Defensive Stocks to Buy During This Chaotic SpellMon, 20 Mar 2023 22:31:05 While it’s always a good idea to balance your portfolio with defensive stocks, the present chaos dramatically incentivizes this subsegment. As you’ve no doubt heard, the U.S. and the rest of the world presently reel from two ...... Read Full Article |
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?Mon, 20 Mar 2023 10:26:10 Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments should keep Merck's (MRK) stock afloat in 2023.... Read Full Article |